NovMetaHealth is a specialized new drug development company that researches and develops first-in-class drugs and high-functional health functional food. NovMetaHealth has secured original technologies such as Alzheimer’s disease, acute pancreatitis, liver cancer medication, and cytokine inhibitor, and is making active efforts in R&D domestically and internationally to commercialize them.
Company Name | NovMetaHealth Co., Ltd. |
---|---|
CEO | Sunwook Hwang |
Establishment | March 17th, 2016 |
Business Type | (M70113) Medication and pharmaceutical R&D |
Main Products | Alzheimer’s disease, acute pancreatitis, liver cancer medication, and cytokine inhibitor |